TimeScale Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

TimeScale Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100	Closed	-$1.04K	–	646
2022 Q4	$1.04K	Hold	100	–	–	﹤0.01%	500
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	505
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	472
2022 Q1	$1K	Hold	100	–	–	﹤0.01%	491
2021 Q4	$1K	Hold	100	–	–	﹤0.01%	488
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	475
2021 Q2	$1K	Hold	100	–	–	﹤0.01%	473
2021 Q1	$1K	Hold	100	–	–	﹤0.01%	469
2020 Q4	$1K	Hold	100	–	–	﹤0.01%	399
2020 Q3	$1K	Hold	100	–	–	﹤0.01%	423
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	413
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	393
2019 Q4	$1K	Hold	100	–	–	﹤0.01%	483
2019 Q3	$1K	Hold	100	–	–	﹤0.01%	462
2019 Q2	$1K	Buy	+100	New	+$1.12K	﹤0.01%	481

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

TimeScale Financial's IRWD Position: Q1 2023 in Review

TimeScale Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 100 shares — an estimated $1.04K sold.

TimeScale Financial first reported a position in IRWD in Q2 2019 and held it in 15 quarters. The position peaked at $1.04K in Q4 2022. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

TimeScale Financial reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
TimeScale Financial sold 100 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $1.04K.
TimeScale Financial first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 15 quarters.
TimeScale Financial's Ironwood Pharmaceuticals position peaked at $1.04K in Q4 2022.
254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on TimeScale Financial's 13F filing for Q1 2023, filed 24 Apr 2023.